ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh.

M D Faruque Pathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.